期刊文献+

金沸草散加减联合西药治疗咳嗽变异性哮喘42例 被引量:10

Clinical Observation on Modified Jinfeicao Powder Combined With Western Medicine for 42 Cases of Cough Variant Asthma
原文传递
导出
摘要 目的观察金沸草散加减联合沙美特罗/丙酸氟替卡松干粉剂治疗咳嗽变异性哮喘的临床疗效。方法将82例咳嗽变异性哮喘患者随机分为治疗组42例和对照组40例。对照组予沙美特罗/丙酸氟替卡松干粉剂吸入治疗,每次1吸,每日2次;治疗组在对照组治疗基础上加用金沸草散加减,每日1剂。治疗8周后评价临床疗效,并观察治疗前后两组患者咳嗽严重程度评分变化及呼气峰流速日间变异率(PEFR)。结果治疗组临床疗效总有效率为90.48%,对照组为67.50%,治疗组疗效明显优于对照组(P<0.05)。两组患者治疗后咳嗽严重程度评分、PEFR均明显下降(P<0.05);治疗后治疗组咳嗽严重程度评分、PEFR均明显低于对照组(P<0.05)。结论金沸草散加减联合沙美特罗/丙酸氟替卡松干粉剂能显著改善咳嗽变异性哮喘患者的临床症状、降低PEFR,疗效确切。 Objective To observe the therapeutic effect of modified Jinfeicao Powder ( Inula Powder) on cough variant asthma Methods Totally 82 cases of cough variant asthma were randomized into the treatment group of 42 cases and control group of 40 cases. The control group was inhaled with Salmeterol/fluticasone propionate dry powder twice daily. The treatment group was added with modified Jinfeicao "Powder one dose daily. The therapeutic effect was evaluated after 8-week treatment. The cough scores and peak expiratory flow rates (PEFRs) were observed before and after treatment in both groups. Results The total effective rate of the treatment group and control group was 90. 48% and 67. 50% respectively, with a significant difference between groups (P 〈0. 05). The cough scores and PEFRs were significantly decreased in both groups after treatment ( P 〈 0. 05 ), especially in the treatment group (P 〈 O. 05). Conclusion Jinfeicao Powder combined with salmeterol/fluticasone can obviously relieve the symp- toms of cough variant asthma and decrease PEFR.
作者 李康 秦晓华
出处 《中医杂志》 CSCD 北大核心 2014年第2期161-163,共3页 Journal of Traditional Chinese Medicine
关键词 咳嗽变异性哮喘 金沸草散 呼气峰流速日间变异率 cough variant asthma Jinfeieao Powder (Inula Powder) peak expiratory flow rate
  • 相关文献

参考文献12

二级参考文献66

  • 1魏伟,梁君山,周爱武,陈敏珠,徐叔云.白芍总甙对白细胞介素-2产生的影响[J].中国药理学通报,1989,5(3):176-179. 被引量:39
  • 2马世平,瞿融,杭秉茜.蝉蜕的免疫抑制和抗过敏作用[J].中国中药杂志,1989,14(8):42-45. 被引量:133
  • 3陈芳瑜,陈红梅.中药超声雾化治疗咳嗽变异性哮喘[J].福建中医药,1996,27(5):34-35. 被引量:28
  • 4杨贵贞 王桂兰 等.甘草LX对小鼠过敏性休克的保护效应[J].中国免疫学杂志,1986,2(1):4-5.
  • 5Glauser FL Variant asthma.Ann Allergy,1972,30:457-459.
  • 6Desai D,Brightling C. Cough due to asthma,cough-variant asthma and non-asthmatic eosinophilic bronchitis.Otolaryngol Clin N Am,2010,43:123-130.
  • 7Fujimura M,Abo M,Ogawa H,et al. Importance of atopic cough,cough variant asthma and sinobronchial syndrome as causes of chronic cough in the Hokuriku area of Japan. Respirology,2005,10:201-207.
  • 8Committee for the Japanese Respiratory Society guidelines for management of cough,Kohno S,Ishida T,et al.The Japanese Respiratory Society guidelines for management of cough.Respirology,2006,11 Suppl 4:135-186.
  • 9Niimi A,Matsumoto H,Takemura M,et al.Relation of airway wall thickness to airway sensitivity and airway reactivity in asthma.Am J Respir Crit Care Med,2003,168:983-988.
  • 10Irwin RS,French CT,Smyrnios NA,et at. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating coughvariant asthma.Arch Intern Med,1997,157:1981-1987.

共引文献1726

同被引文献100

引证文献10

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部